
Neurologist warns of serious issues which can be triggered by playing with cute pet owned by millions
Dr Baibing Chen, from the University of Michigan, shared the warning on TikTok, stating that cats can harbour dangerous bacteria that could pose a serious threat to owners.
In the video, which has been viewed over 124,000 times, he urged his followers to seek immediate medical attention if they experience any unusual symptoms after being scratched, bitten or even licked by a cat.
Speaking about the one thing he would 'never ignore', Dr Chen said: 'I once saw a teenage patient who developed sudden confusion, severe headaches and trouble walking.'
The patient also presented with extreme fatigue and coordination issues, which her parents described as unusual.
The clinical instructor added: 'We also noticed a decrease in her vision in one eye. Further investigation showed it was inflammation of the optic nerve and the retina which explained her vision loss.'
But doctors could not come up with a diagnosis that could explain her symptoms after ruling out the 'usual suspects' including stroke, meningitis and autoimmune disease—all of which can cause neurological disturbances.
'It wasn't until we noticed a few scratches on her arm that we asked about any recent injuries or exposures and that's when her mother mentioned they had recently adopted a kitten.
'This detail was key leading to the confirmation of bartonella henselae infection—the bacteria that causes cat scratch disease.'
The disease can spread to humans through a scratch contaminated with flea feces—most commonly from kittens.
Infected cats can also spread the bacteria by licking a person's open wound.
Cat scratch disease most commonly affects children under the age of 15 who are less likely to wash their hands after interacting with their pet cat.
It's estimated that there are approximately 12.5 million pet cats in the UK, with nearly 30 per cent of British households having at least one cat.
In the US, 37 per cent of households have at least one cat. Figures estimate the US' total cat population stands at 73.8 million.
Dr Chen said: 'Most people with this infection experience mild symptoms like swollen lymph nodes, fever and fatigue, but in rare cases this condition can affect the nervous system and eyes.'
Rarely, according to the US Centres for Disease Control and Prevention (CDC), this can develop into infections of the liver, spleen, brain, bones and even heart—a condition known as endocarditis.
Whilst most scratches do not result in CSD, Dr Chen said it's best to stay vigilant and keep scratch wounds clean and keep an eye out for tell-tale symptoms including a fever, swollen lymph nodes and a pustule near the scratch.
These more extreme reactions tend to occur in people with weakened immune systems, such as cancer patients, elderly people or those with HIV.
However, the risk of infection can be minimised through keeping cats indoors and away from stray cats who are more likely to carry diseases.
But, he said this does not mean you should stay away from your cat.
'This case is a reminder that something as seemingly harmless as a playful scratch can in rare cases lead to serious health issues.
'The key here is awareness. If a scratch, bite or lick is followed by unusual symptoms like persistent headaches, vision changes or confusion sharing the detail with your doctor can make all the difference.'
The warning comes as Britain was rocked by fresh rabies fears back in June, after a woman died after catching the virus on holiday in Morocco.
Health officials revealed that the grandmother, Yvonne Ford, 59, contracted the illness following contact with a stray dog.
There have been less than 10 cases of human rabies associated with animal exposures abroad reported in the UK since 2000.
However, the UKHSA stressed there was 'no risk to the wider public' given there is 'no documented evidence of rabies passing between people'.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
Menopause made my hair fall out. Then I discovered a new hair-loss solution. This is the secret ALL midlife women need to know
For me, midlife has brought various indignities, as well as many joys. But standing over a sink to count the number of hairs that had come out in my brush one morning has to be among the more distressing aspects. For the record, it was 201. And why was I counting them? Because I'd searched 'how to tell if your hair is falling out' online – and according to Dr Google, anything over 100 strands was a cause for concern.


The Independent
2 hours ago
- The Independent
WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs
WeightWatchers was slower to adapt to the emergence of anti-obesity jabs than rivals, its boss has admitted, as the 62-year-old brand strives to catch up with rapidly evolving attitudes towards weight loss. Tara Comonte, chief executive of the US-based business, said it had a lot of work to do after going through a 'reset'. WeightWatchers recently announced it had emerged from bankruptcy after writing off a portion of the 1.15 billion US dollar (£860 million) debt on its balance sheet. It came as the business was competing with the emergence of GLP-1s – the scientific term for weight loss jabs, which work by reducing food cravings – and a new wave of apps and advice spreading on social media. Ms Comonte told the PA news agency that it 'wasn't as quick to medical weight loss solutions' as some other firms in the US, notably so-called 'telehealth' businesses that offer healthcare remotely. WeightWatchers, which runs some 20,000 workshops each month globally, is now 'at the beginning of the journey' towards forging a new place in the industry and meeting demand from current and future members, Ms Comonte said. 'This whole industry is going through somewhat of a reset and we have exciting work to do,' she told the PA news agency. 'This is a moment where, possibly more than ever before, people are talking about weight, and weight health… where people are seeking more education than ever before, and there are more voices than ever before.' Ms Comonte said the brand was known for 'trust and science' and it was important to harness that 'as there are more and more voices in the ecosystem'. WeightWatchers recently partnered with anti-obesity drugs provider CheqUp in the UK so patients taking the medication can access its 'companion' diet and lifestyle support app. It forms part of its efforts to muscle into the market by offering behavioural strategies and community-based support to people using or coming off the medication. 'There's no 'us and them' anymore,' Ms Comonte told PA, hitting back at weight loss jabs often being pitted as rivals to its model. Dr Kim Boyde, WeightWatchers' newly appointed chief medical officer, said not all its members will want or need weight loss medication – but stressed that it was 'imperative' the programme offers it to those that might benefit. Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects.


Reuters
3 hours ago
- Reuters
Roche to investigate whether new drug can delay or prevent Alzheimer's disease
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.